GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Share-based Compensation (2009 - 2012)

Updated

Gsk (GSK) recorded Share-based Compensation of $381.85 million in the year ended Dec 31, 2023, down 10.8% from $428.21 million a year earlier.

Analysis

Gsk (GSK) Share-based Compensation (2009 - 2012) Analysis & Trends

Starting with the year ended Dec 31, 2013, Gsk's Share-based Compensation history includes 9 years.

  • Annual Share-based Compensation has a five-year compound annual growth rate of -4.5% (years ended Dec 2018 to Dec 2023).
  • The figure for the year ended Dec 31, 2023 is the lowest annual Share-based Compensation in data going back to the year ended Dec 31, 2013.
  • Per Business Quant data, GSK's Share-based Compensation was $428.21 million in the year ended Dec 31, 2022 (-9.3%) and $471.93 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 458.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 166.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 231.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 249.00 Mn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 353.29 Mn
Dec 31, 2011 311.17 Mn
Dec 31, 2010 282.80 Mn
Dec 31, 2009 292.39 Mn
API Access

Gsk Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GSK&period=max&api_key=YOUR_API_KEY